2016

Farma Industria Ticino and Credit Suisse Award for best student

ASSEMBLEA GENERALE ORDINARIA
Helsinn Group hosts a Satellite Symposium on shared decision making in supportive care, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting 2016 on June 24th

Helsinn Group to present at ASCO pooled follow up efficacy data analysis from two Phase III studies for anamorelin in cachectic patients with non-small cell lung cancer (NSCLC)

Helsinn to Present at UBS Healthcare Conference in New York

Helsinn support the Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award in Cancer Supportive Care whit research funding support for promising young physicians

Helsinn Healthcare SA, The University of Texas MD Anderson Cancer Center enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care

HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA CANADA FOR THE DISTRIBUTION AND LICENSING RIGHTS OF AKYNZEO® (NETUPITANT/PALONOSETRON combo) IN CANADA

RIVOPHARM acquires HOLSTEN Pharma

Linkedin